NCT03895099View on ClinicalTrials.gov

New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

September 4, 2020

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions
Infertility
Interventions
DRUG

Desogestrel early follicular phase

Start of ovarian stimulation in early follicular phase

DRUG

Desogestrel medium follicular phase

Start of ovarian stimulation in medium follicular phase

DRUG

Desogestrel ovulatory phase

Start of ovarian stimulation in ate follicular phase

DRUG

Desogestrel late follicular phase

Start of ovarian stimulation in ovulatory Phase

DRUG

Desogestrel luteal phase

Start of ovarian stimulation in luteal phase

Trial Locations (4)

35043

Clinique de la Sagesse, Rennes

Unknown

CHRU Lille, Lille

CHU Bondy, Paris

CHU Tenon, Paris

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Centre Hospitalier Intercommunal Creteil

OTHER

NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors | Biotech Hunter | Biotech Hunter